Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase III trial of tosedostat in elderly patients with high risk myelodysplastic syndromes or secondary acute myeloid leukaemia who have failed to respond adequately to hypomethylating agents.

Trial Profile

Phase III trial of tosedostat in elderly patients with high risk myelodysplastic syndromes or secondary acute myeloid leukaemia who have failed to respond adequately to hypomethylating agents.

Status: Planning
Phase of Trial: Phase III

Latest Information Update: 13 Jan 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tosedostat (Primary)
  • Indications Acute myeloid leukaemia; Myelodysplastic syndromes
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 11 Jan 2016 Planned initiation date changed from 1 Dec 2012 to 1 Jan 2016, as per CTI BioPharma media release.
    • 01 Aug 2012 Planned initiation date changed from 1 Jun 2012 to 1 Dec 2012.
    • 13 Dec 2011 Planned initiation date changed from 1 Oct 2011 to 1 Jun 2012, according to a Chroma Therapeutics media release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top